AI assistant
AtriCure, Inc. — Director's Dealing 2021
Jan 6, 2021
31802_dirs_2021-01-06_4aa7ab9e-729c-474f-87c1-a3fe50093a6e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2021-01-04
Reporting Person: Collar Mark A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-04 | Common Stock | S | 3000 | $55.36 | Disposed | 75558 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5300 | Indirect |
Footnotes
F1: These shares were sold pursuant to a 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $54.72 to $55.78 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.